Williams & Novak, LLC Harvard Bioscience Inc Transaction History
Williams & Novak, LLC
- $104 Billion
- Q4 2024
A detailed history of Williams & Novak, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Williams & Novak, LLC holds 99,210 shares of HBIO stock, worth $169,649. This represents 0.2% of its overall portfolio holdings.
Number of Shares
99,210Holding current value
$169,649% of portfolio
0.2%Shares
1 transactions
Others Institutions Holding HBIO
# of Institutions
95Shares Held
31.4MCall Options Held
700Put Options Held
2.1K-
Black Rock Inc. New York, NY2.84MShares$4.86 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.77MShares$4.74 Million0.44% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.72MShares$4.64 Million0.87% of portfolio
-
Amh Equity LTD2.39MShares$4.08 Million8.88% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$3.68 Million0.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $71.2M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...